Dacoplice 15mg tablet contains the active substance Dacomitinib. It is an antineoplastic drug that belongs to the class tyrosine kinase inhibitor. It is used as a first-line treatment in adults with a type of lung cancer called non-small cell lung cancer which has spread to other parts of the body, and if a test has shown that your cancer has certain changes in a gene called EGFR (epidermal growth factor receptor).
Dacoplice 30mg tablet contains the active substance Dacomitinib. It is an antineoplastic drug that belongs to the class tyrosine kinase inhibitor. It is used as a first-line treatment in adults with a type of lung cancer called non-small cell lung cancer which has spread to other parts of the body, and if a test has shown that your cancer has certain changes in a gene called EGFR (epidermal growth factor receptor).
Introduction to Dacoplice 45mg Tablet
Dacoplice 45mg tablet contains the active substance Dacomitinib. It is an antineoplastic drug that belongs to the class tyrosine kinase inhibitor. It is used as a first-line treatment in adults with a type of lung cancer called non-small cell lung cancer which has spread to other parts of the body, and if a test has shown that your cancer has certain changes in a gene called EGFR (epidermal growth factor receptor).
GATILOX EYE 5ML DROPS ₦1,874.50
2 B12 CAP 15`S ₦5,921.50
Duphaston Dydrogesterone 10mg Tablet ₦5,800.00
DEPLATT A 150MG TAB 15`S ₦1,694.25
SALACTIN PAINT 10ML ₦8,683.25
CHEKFALL 5% 60ML TOPICAL SOLUTION ₦16,047.50
DOUX ULTRA MOIST BAR ₦3,073.25
DACOPLICE 15mg Tablet 30?s
Dacoplice 15mg tablet contains the active substance Dacomitinib. It is an antineoplastic drug that belongs to the class tyrosine kinase inhibitor. It is used as a first-line treatment in adults with a type of lung cancer called non-small cell lung cancer which has spread to other parts of the body, and if a test has shown that your cancer has certain changes in a gene called EGFR (epidermal growth factor receptor).
DACOPLICE 30mg Tablet 30?s
Dacoplice 30mg tablet contains the active substance Dacomitinib. It is an antineoplastic drug that belongs to the class tyrosine kinase inhibitor. It is used as a first-line treatment in adults with a type of lung cancer called non-small cell lung cancer which has spread to other parts of the body, and if a test has shown that your cancer has certain changes in a gene called EGFR (epidermal growth factor receptor).
Introduction to Dacoplice 45mg Tablet Dacoplice 45mg tablet contains the active substance Dacomitinib. It is an antineoplastic drug that belongs to the class tyrosine kinase inhibitor. It is used as a first-line treatment in adults with a type of lung cancer called non-small cell lung cancer which has spread to other parts of the body, and if a test has shown that your cancer has certain changes in a gene called EGFR (epidermal growth factor receptor).
DACOPLICE 45mg Tablet 30?s
Dacotin 100mg Injection 1?S
Dacotin 50mg Injection 1?S